FEDERALSEC 10-K Item 1CFirst filing
Filed Apr 28, 2026bd_06e0be7c18aa5b72
PDS Biotechnology Corporation filed a Form 10-K/A (Amendment No. 1) for fiscal year ended December 31, 2025, amending Part III of its Annual Report to include director/officer governance, compensation, and related disclosures. The filing contains general cybersecurity risk oversight language noting the Audit Committee reviews cybersecurity risks, but discloses no specific cybersecurity incident or breach affecting the company.